Literature DB >> 20692778

Which indicators can public health authorities use to monitor prescription drug abuse and evaluate the impact of regulatory measures? Controlling High Dosage Buprenorphine abuse.

Vanessa Pauly1, Elisabeth Frauger, Vincent Pradel, Franck Rouby, Julie Berbis, François Natali, Patrick Reggio, Hervé Coudert, Joelle Micallef, Xavier Thirion.   

Abstract

BACKGROUND: Two methods have been recently developed from a drug reimbursement database to provide useful indicators for public health authorities concerning the abuse potential of psychotropic drugs. The doctor-shopping indicator (DSI) measures the proportion of the drug obtained by doctor shopping among the overall quantity of the drug reimbursed and the clustering method reveals subgroups of deviant patients.
OBJECTIVE: The objective of the study was to analyze and compare indicators resulting from these two methods, applied to High Dosage Buprenorphine (HDB) (a product well-known to be diverted in France), in order to determine which public health authorities needs they answer. DATA ANALYSIS: The patients with reimbursed HDB were grouped using the clustering method in terms of drug dispensations characteristics over a nine month period. The characteristics of the resulting subgroups, including their DSI, were then compared.
RESULTS: 4787 Patients (73.4%) had no measurable doctor-shopping behaviour. But the comparison of the two methods demonstrated that the more a patient's profile was characterized by deviant behavior, the higher was the DSI: from 0.4% in a subgroup with a median profile to 72% in a subgroup with a deviant profile.
CONCLUSION: These two methods are useful surveillance tools for public health authorities: the clustering method may help devise pertinent intervention strategies to reduce prescription drug abuse while the DSI method provides quantitative information demonstrating whether these strategies are useful. We discuss the advantages and disadvantages of using these two methods as useful indicators for public health authorities.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20692778     DOI: 10.1016/j.drugalcdep.2010.06.016

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  4 in total

1.  Assessing opioid shopping behaviour: a large cohort study from a medication dispensing database in the US.

Authors:  M Soledad Cepeda; Daniel Fife; Wing Chow; Gregory Mastrogiovanni; Scott C Henderson
Journal:  Drug Saf       Date:  2012-04-01       Impact factor: 5.606

Review 2.  Harmonizing post-market surveillance of prescription drug misuse: a systematic review of observational studies using routinely collected data (2000-2013).

Authors:  Bianca Blanch; Nicholas A Buckley; Leigh Mellish; Andrew H Dawson; Paul S Haber; Sallie-Anne Pearson
Journal:  Drug Saf       Date:  2015-06       Impact factor: 5.606

3.  Intimate partner violence and prescription of potentially addictive drugs: prospective cohort study of women in the Oslo Health Study.

Authors:  Lise Eilin Stene; Grete Dyb; Aage Tverdal; Geir Wenberg Jacobsen; Berit Schei
Journal:  BMJ Open       Date:  2012-04-05       Impact factor: 2.692

4.  The current status of opioid maintenance treatment in France: a survey of physicians, patients, and out-of-treatment opioid users.

Authors:  Amine Benyamina
Journal:  Int J Gen Med       Date:  2014-09-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.